Taganov; Konstantin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Taganov; Konstantin.The latest application filed is for "substituted pyrimidines for treating bacterial infections".

Company Profile

9.13.13

Taganov; Konstantin - San Diego CA
Taganov; Konstantin - Pasadena CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibacterial compounds Grant 11,021,471 - Teng , et al. June 1, 2	2021-06-01
Substituted Pyrimidines For Treating Bacterial Infections App 20210078957 - TENG; Min ; et al.	2021-03-18
Substituted pyrimidines for treating bacterial infections Grant 10,875,832 - Teng , et al. December 29, 2	2020-12-29
Antibacterial Compounds App 20200255413 - Kind Code	2020-08-13
Pyrone based compounds for treating bacterial infections Grant 10,611,747 - Teng , et al.	2020-04-07
Antibacterial Compounds App 20200095236 - TENG; Min ; et al.	2020-03-26
Hydroxypyrimidinone And Hydroxypyrimidinone Based Compounds For Treating Bacterial Infections App 20200010427 - TENG; Min ; et al.	2020-01-09
MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders Grant 10,435,689 - Baltimore , et al. O	2019-10-08
Substituted hydroxypyrimidinones for treating bacterial infections Grant 10,414,735 - Teng , et al. Sept	2019-09-17
Hydroxypyridinone And Hydroxypyrimidinone Based Compounds For Treating Bacterial Infections App 20180327365 - TENG; Min ; et al.	2018-11-15
Pyrone Based Compounds For Treating Bacterial Infections App 20180319761 - TENG; Min ; et al.	2018-11-08
Microrna Inhibition For The Treatment Of Inflammation And Myeloproliferative Disorders App 20180187193 - Baltimore; David ; et al.	2018-07-05
Microrna inhibition for the treatment of inflammation and myeloproliferative disorders Grant 9,862,948 - Baltimore , et al. January 9, 2	2018-01-09
Microrna Inhibition For The Treatment Of Inflammation And Myeloproliferative Disorders App 20160244754 - Baltimore; David ; et al.	2016-08-25
MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders Grant 9,290,761 - Baltimore , et al. March 22, 2	2016-03-22
Modulating immune system development and function through microRNA MIR-146 Grant 9,090,894 - Baltimore , et al. July 28, 2	2015-07-28
Microrna Inhibition For The Treatment Of Inflammation And Myeloproliferative Disorders App 20140220049 - Baltimore; David ; et al.	2014-08-07
Microrna inhibition for the treatment of inflammation and myeloproliferative disorders Grant 8,697,672 - Baltimore , et al. April 15, 2	2014-04-15
Modulation of innate immunity receptors' signaling by microRNAs miR-146a and miR-146b Grant 8,669,235 - Baltimore , et al. March 11, 2	2014-03-11
Modulating Immune System Development And Function Through Microrna Mir-146 App 20110258716 - Baltimore; David ; et al.	2011-10-20
Modulating Immune System Development And Function Through Microrna Mir-146 App 20090203136 - Baltimore; David ; et al.	2009-08-13
Microrna Inhibition For The Treatment Of Inflammation And Myeloproliferative Disorders App 20080300211 - Baltimore; David ; et al.	2008-12-04
MODULATION OF INNATE IMMUNITY RECEPTORS' SIGNALING BY microRNAs miR-146a AND miR-146b App 20070232553 - Baltimore; David ; et al.	2007-10-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.